Press Releases

AMA statement on FDA approval of implant to fight opioid addiction

| 1 Min Read

"The AMA is pleased the FDA approved a new implantable option to help treat patients with substance use disorders. With nearly 2 million Americans needing treatment for opioid use disorder, patients will benefit from increased options for medication-assisted treatment.

 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Pharmacist speaks with customer

Physician-led care is best prescription for health of nation

| 5 Min Read
Reviewing data on a laptop

Turning data into action to strengthen physician well-being

| 7 Min Read
Doctor raising hand to ask a question in a seminar

Building physician leaders who guide with heart and skill

| 7 Min Read
Hand signing a contract

What doctors wish patients knew about end-of-life care planning

| 6 Min Read